Kang et al. revealed a direct correlation between four tumor markers (CEA, CA125, CYFRA21-1, and SCC-Ag) in advanced NSCLC and the patient response to PD-1/PD-L1 inhibitors (103). The gene discussed is CD274; the disease is non-small cell lung carcinoma.